Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Absci Corporation

< Previous 1 2 Next >
Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Participate in the Piper Sandler 35th Annual Healthcare Conference
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci Reports Business Updates and Third Quarter 2023 Financial and Operating Results
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases
From Absci Corporation
Via GlobeNewswire
Tickers ABSI DE
Absci to Participate in Upcoming Investor Conferences
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci Announces Speaker Lineup for Inaugural R&D Day, Including Renowned Global Business Leader Sandi Peterson and VP of Applied Research at NVIDIA Jonathan Cohen
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Host R&D Day on October 4, 2023
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Participate in Upcoming Investor Conferences
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci Appoints Zach Jonasson, Ph.D., as Chief Financial Officer and Chief Business Officer
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci and Caltech Join Forces, Bolstered by Major Grant, to Accelerate Affordable HIV Therapeutic Vaccine Development
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Participate in the UBS MedTech, Tools and Genomics Summit 2023
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Participate in the Canaccord Genuity 43rd Annual Growth Conference
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Participate in the Morgan Stanley 2nd Annual Biotechnology AI Summit
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci Evolves its Board of Directors with HealthTech Luminary Frans van Houten, Former CEO of Philips
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci Reports Business Updates and First Quarter 2023 Financial and Operating Results
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
University of Oxford’s Kennedy Institute of Rheumatology Partners with Absci to Accelerate AI-Driven Immunotherapies
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Participate in the 22nd Annual Needham Virtual Healthcare Conference
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci Partners with Bioinformatics Company M2GEN to Accelerate Drug Creation for Oncology
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Participate in the B. Riley Securities' Life Sciences Tools Conference - Proteomics Setting the Blueprint for Innovative Drug Creation
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci Expands in Europe with Launch of New Innovation Center and Additional Senior Leadership in Switzerland
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Participate in the 43rd Annual Cowen Health Care Conference
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
St. John’s Cancer Institute Partners with Absci to Expedite Development of Cancer Therapies
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci Deepens Scientific Advisory Board to Accelerate Generative AI Drug Creation
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci First to Create and Validate De Novo Antibodies with Zero-Shot Generative AI
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Participate in the 41st Annual J.P. Morgan Healthcare Conference
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Participate in the 41st Annual J.P. Morgan Healthcare Conference
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.